Teplizumab treatment for stage 2 type 1 diabetes: a real-world evaluation of metabolic and immunological outcomes.
Saved in:
| Title: | Teplizumab treatment for stage 2 type 1 diabetes: a real-world evaluation of metabolic and immunological outcomes. |
|---|---|
| Authors: | Karakus KE; Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO, USA., Chesshir L; Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO, USA., Walker S; Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO, USA., Baschal EE; Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO, USA., McDaniel KA; Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO, USA., Triolo TM; Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO, USA., Steck AK; Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO, USA., Frohnert BI; Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO, USA., Gottlieb PA; Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO, USA., Michels AW; Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO, USA., Simmons KM; Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO, USA. Kimber.simmons@cuanschutz.edu. |
| Source: | Diabetologia [Diabetologia] 2026 May; Vol. 69 (5), pp. 1164-1175. Date of Electronic Publication: 2026 Jan 15. |
| Publication Type: | Journal Article; Observational Study |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0006777 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0428 (Electronic) Linking ISSN: 0012186X NLM ISO Abbreviation: Diabetologia Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
